SOUTH SAN FRANCISCO, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK), today announced upcoming presentations at the 2023 Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions on October 6, 2023, and at the Heart Failure Society of America (HFSA) Annual Scientific Meeting, taking place from October 6-9, 2023, both taking place in Cleveland, OH.
2023 HCMS Scientific Sessions
Poster Abstract Presentations
Title: Baseline Characteristics of Patients in SEQUOIA-HCM: A Phase 3 Trial of Aficamten in Obstructive Hypertrophic Cardiomyopathy
Presenter: Martin S. Maron, M.D., Director of the Hypertrophic Cardiomyopathy Center at Lahey Hospital and Medical Center
Date: October 6, 2023
Session Title: Poster Abstract Presentations
Session Time: 1:00 – 1:45 PM ET
Location: Hilton Cleveland Downtown
HFSA Annual Scientific Meeting
Poster Presentations
Title: Characteristics and Procedural Complications of Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy in the United States
Presenter: Ahmed Altibi, M.D., MPH, Cardiology Fellow, Division of Cardiovascular Medicine, Oregon Health & Science University
Date: October 7, 2023
Session Title: ePoster Viewing Sessions - ePoster Viewing Session II
Poster Number: 139
Session Time: 8:00 – 9:00 AM ET
Presentation Time: 8:30 – 9:00 AM ET
Location: Exhibit Hall‚ ePoster Hub
Title: Symptoms and Complications Significantly Increase the Logistic and Economic Burden of Obstructive Hypertrophic Cardiomyopathy - Results from Medical and Pharmacy Claims Data
Presenter: Meiling Chen, M.D., Cardiology Research Fellow, HCM Center of Excellence, University of California, San Francisco Medical Center
Date: October 7, 2023
Session Title: ePoster Viewing Sessions - ePoster Viewing Session III
Poster Number: 163
Session Time: 1:00 – 2:30 PM ET
Presentation Time: 1:00 – 1:30 PM ET
Location: Exhibit Hall‚ ePoster Hub
Title: Cardiovascular Hospitalizations Post Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy: A 3-year Analysis of ...